International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: https://doi.org/10.5281/zenodo.14597896
Original Research Article
Role of Milan system reporting for categorizing salivary gland lesions in cytopathology
Published
Dec. 31, 2024
Abstract

Introduction:Salivary glands are exocrine organs responsible for the production and secretion of saliva and consist of the parotid, submandibular, sublingual and minor salivary glands that are numerous and widely distributed throughout the mouth and oropharynx. Salivary glands neoplasms accounts for less than 3% of all the head and neck tumors. (1) FNAC is a useful method for evaluating suspicious salivary gland lesions due to its low cost, minimum morbidity, rapid turn around time, high specificity and sensitivity. (2) Among the primary epithelial tumors, 64-80% occurs in the parotid glands, 7-11% occurs in the submandibular, less then 1% occurs in the sublingual and 9-23% occur in the minor salivary glands. (3) Material and Method: The study was conducted on salivary gland lesions over the period of 6months, with total number of 35cases in the Department of Pathology. Results:There is a definite male predominance in lesions of salivary glands. Parotid is the most common site for occurrence of salivary gland lesions. Benign neoplasm more common in age group below 50years and malignancies in above 50years of age groups. A total 35 salivary gland lesions were examined and 22 were males and 13 were females According to MILAN system majority of cases belongs to Neoplasm benign (37%) followed by non neoplastic(28.6%), malignant(25.7%), non diagnostic(5.8%) and Suspicious of malignancy(2.9%). Conclusion:FNAC has an immense significance as a primary and most effective as well as cost effective screening test in detecting and differentiating salivary glands lesions. The high sensitivity, specificity and diagnostic accuracy of cytologic reporting of salivary gland lesions based on Milan nomenclature in our study reflect the positive contribution of the MSRSGC towards accurately categorizing the lesions by which risk of malignancy can be assessed. This helps the clinicians for further management.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
1109 Views
434 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved